Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO1 pseudogene 6 (MTCO1P6) belongs to a class of mitochondrial pseudogenes found in the human genome. Unlike the true MT-CO1 gene—which encodes cytochrome c oxidase I, a critical subunit of Complex IV in the mitochondrial electron transport chain—MTCO1P6 is classified as a pseudogene and does not produce a functional protein. Pseudogenes traditionally arise from duplication or retrotransposition events and generally lack biological activity—they are not transcribed or translated into functional products, nor are they typical targets in drug development or disease biology[3]. MTCO1P6 is an approved locus by the HUGO Gene Nomenclature Committee and is distinct from the functional mitochondrial gene MT-CO1, which has known pathological and biomarker roles, but MTCO1P6 itself does not share these properties[1][3]. MTCO1P6 should not be confused with MT-CO1 (COX1), which does encode an enzymatic protein pivotal for cellular respiration and disease processes such as complex IV deficiency, Leber's hereditary optic neuropathy, and more[1][4]. The pseudogene MTCO1P6 has no direct biological function or disease association and is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO1 pseudogene 6 (MTCO1P6).